Korean drugmaker Mezzion has filed a suit against Dr Reddy’s Laboratories (DRL) in a US court alleging that the Indian pharmaceutical company hid significant deficiencies and misrepresented compliance in its manufacturing practices. Mezzion, which ha
New Delhi: India's second largest drugmaker by sales, Dr. Reddy's Laboratories Ltd, has posted a 25 per cent rise in quarterly net profit, but fell short of analysts' estimates due to a rise in expenses.Net
New Delhi: Pharma major Dr Reddy's Laboratories Ltd's net profit rose 64 per cent to Rs 618 crore in the third quarter ended December 31, 2013, as against Rs 378 crore in the corresponding quarter
Top News
Latest News
